Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 1,25-dihydroxycholecalciferol: the metabolite of vitamin D responsible for increased intestinal calcium transport.

× No keyword cloud information.

17 in total

1. Antigenic and catalytic disparity in the distribution of cytochrome P-450-dependent 25-hydroxyvitamin D3-1 alpha- and 24-hydroxylases.

Authors: K Takezawa; B Moorthy; M L Mandel; J C Garancis; J G Ghazarian
Journal: Histochemistry Date: 1990

Review 2. The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Authors: Luisella Cianferotti; Claudio Cricelli; John A Kanis; Ranuccio Nuti; Jean-Y Reginster; Johann D Ringe; Rene Rizzoli; Maria Luisa Brandi
Journal: Endocrine Date: 2015-05-01 Impact factor: 3.633

3. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].

Authors: G Offermann; K Schaefer; A Schulz; G Delling
Journal: Klin Wochenschr Date: 1976-07-01

4. Control of 25-hydroxycholecalciferol metabolism by parathyroid glands.

Authors: M Garabedian; M F Holick; H F Deluca; I T Boyle
Journal: Proc Natl Acad Sci U S A Date: 1972-07 Impact factor: 11.205

5. The stimulation of 1,25-dihydroxycholecalciferol metabolism in vitamin D-deficient rats by 1,25-dihydroxycholecalciferol treatment.

Authors: C A Frolik; H F DeLuca
Journal: J Clin Invest Date: 1973-03 Impact factor: 14.808

6. Treatment of uremic bone disease. Action of 5,6-trans-25-hydroxycholecalciferol (a vitamin D-analog) in chronic renal failure.

Authors: D von Herrath; K Schaefer; D Kraft; H G Grigoleit; P Koeppe
Journal: Klin Wochenschr Date: 1973-10-01

1,25-dihydroxycholecalciferol: the metabolite of vitamin D responsible for increased intestinal calcium transport.

1. Antigenic and catalytic disparity in the distribution of cytochrome P-450-dependent 25-hydroxyvitamin D3-1 alpha- and 24-hydroxylases.

Review 2. The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

3. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].

4. Control of 25-hydroxycholecalciferol metabolism by parathyroid glands.

5. The stimulation of 1,25-dihydroxycholecalciferol metabolism in vitamin D-deficient rats by 1,25-dihydroxycholecalciferol treatment.

6. Treatment of uremic bone disease. Action of 5,6-trans-25-hydroxycholecalciferol (a vitamin D-analog) in chronic renal failure.

7. Metabolism of 1,25-dihydroxycholecalciferol in the rat.

8. Essential fatty acid restriction inhibits vitamin D-dependent calcium absorption.

Review 9. The efficacy of calcitriol therapy in the management of bone loss and fractures: a qualitative review.

10. Vitamin D metabolism during pregnancy and lactation in the rat.